Delivery Order SPE2DB22D1106-SPE2DB25FEHD7
Award Date
4/10/25
Potential Completion Date
4/11/25
Potential Value
$5.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,070.90 order is for 2 milligram vials of Cathflo Activase, a pharmaceutical product. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,264.07, is for the delivery of the pharmaceutical product CATHFLO ACTIVASE 2 MG VIALS. The contract is a firm fixed-price delivery order with an ultimate completion date of December 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,157.38, is for the delivery of 4,567,908,517 units of the medication Cathflo Activase 2 mg vials. The contract has a firm fixed price pricing type and an ultimate completion date of April 15, 2025. There is no set-aside designation noted for this award. AmerisourceBergen holds a...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (doing business as Amerisourcebergen). The contract is for the delivery of 2 mg vials of the pharmaceutical product Cathflo Activase, with a potential value of $6,447.68 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Cathflo Activase 2 mg vials. The contract has a ceiling value of $2,570.16 and a period of performance through March 14, 2024. AmerisourceBergen Drug Corp is the prime contractor and there is no set-aside designation. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price of $3,393.60 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a medical product, with a period of performance through January 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of Cathflo Activase 2 mg vials, a specialty pharmaceutical product, to support military treatment programs and facilities. The total ceiling value of the order is $1,839.49 with a period of performance through March 28,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $1,378.48 firm fixed-price contract is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a pharmaceutical product, with a performance period ending on May 21, 2024. The award is not associated with a set-aside. Amerisourcebergen holds a large Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,213.34 firm fixed-price contract is for the supply of 4562520291 CATHFLO ACTIVASE 2 MG VIALS medical product. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,008.57 order is for the supply of CATHFLO ACTIVASE 2 MG VIALS and has a completion date of March 4, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies,...